Herceptin (trastuzumab) now offers a significant new approach for treating metastatic breast cancer
September 1999
The recent approval of Herceptin (trastuzumab) now offers a significant new approach for treating metastatic breast cancer.
Herceptin is the first monoclonal antibody for breast cancer.
It targets HER2...a protein that stimulates the growth of breast cancer cells. This type of breast cancer tends to be more aggressive and leads to shorter survival.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote